Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fludarabine phosphate, quantity: 50 mg - injection, concentrated - excipient ingredients: dibasic sodium phosphate dihydrate; sodium hydroxide; water for injections; nitrogen - fludarabine ebewe is indicated for the treatment of b-cell chronic lymphocytic leukaemia.

United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) - clindamycin phosphate 1.2% and tretinoin 0.025% gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older. clindamycin phosphate 1.2% and tretinoin 0.025% gel is contraindicated in patients with regional enteritis, ulcerative colitis, or history of antibiotic-associated colitis. pregnancy category c. there are no well-controlled trials in pregnant women treated with clindamycin phosphate 1.2% and tretinoin 0.025% gel. clindamycin phosphate 1.2% and tretinoin 0.025% gel should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. clindamycin phosphate 1.2% and tretinoin 0.025% gel was tested for maternal and developmental toxicity in new zealand white rabbits with topical doses of 60, 180 and 600 mg/kg/day. clindamycin phosphate 1.2% and tretinoin 0.025% gel at 600 mg/kg/day (approximately 12 times the recommended clinical dose assuming 100% absorption and based on body surface area comparison) was considered to be the no-observed-adve

United States - English - NLM (National Library of Medicine)

eon labs, inc. - carisoprodol (unii: 21925k482h) (carisoprodol - unii:21925k482h), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - carisoprodol 200 mg - carisoprodol, aspirin and codeine phosphate tablets, usp are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. limitations of use carisoprodol, aspirin and codeine phosphate tablets, usp should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration (see dosage and administration ). carisoprodol, aspirin and codeine phosphate tablets are contraindicated for: • all children younger than 12 years of age (see warnings) • post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ). carisoprodol, aspirin and codeine phosphate tablets are also contraindicated in patients with: carisoprodol, aspirin, and codeine phosphate tablets contains codeine. codeine in combination with carisoprodol and aspirin is a schedule iii

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - tilmicosin phosphate - oral powder, pre-mix - tilmicosin phosphate antibiotic active 200.0 g/kg - antibiotic & related - pigs | boar | gilt | piglet | sow | swine - pneumonia | bacterial pneumonia

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - tylosin as the phosphate - oral powder, pre-mix - tylosin as the phosphate antibiotic active 250.0 g/kg - antibiotic & related - cattle | pigs | poultry broilers (meat for human consum) | pullet - replacement | beef | boar | bos indicus | bos taurus | bovin - ileitis | improve feed efficiency | liver abscess | necrotic enteritis | promote animal growth | swine dysentery | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - tylosin as the phosphate - oral powder, pre-mix - tylosin as the phosphate antibiotic active 100.0 g/kg - antibiotic & related - cattle | pigs | poultry | poultry broilers (meat for human consum) | beef | boar | bos indicus | bos taurus | bovine | breeders - antibiotic - anti-infective | bacterial infection | ileitis | liver abscess | mineral and nutritional additive | necrotic enteritis | promote animal growth | abrasions | abscesses | acetonaemia | actinobacillosis | airsacculitis | amino acid supplement | amino acids | amoxycillin sensitive bacteria | antiseptic | associated with viral disease | avian mycoplasmas | blackhead | body odours | bone fragility | bone growth | bowed tendons | broad spectrum | burns | calcium supplement | cartilage strength | coccidiosis | coliform complex | conjunctivitis | copper deficiency | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | egg shell | endometritis | enteric diseases | enzootic pneumonia | fatty acid deficiency | fatty liver | feed conversion | feed efficiency | finishing | fungal infections | girth galls | glucose | gram negative organisms | gram positive organisms | grass tetany | growth promotion | growth rate | hepatotoxic drugs | hypocalcaemia | hypo

Ireland - English - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - fludarabine phosphate - concentrate for soln for inf - 25 micromol

Malta - English - Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - fludarabine phosphate - powder for solution for infusion or injection - fludarabine phosphate 50 mg - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - tenofovir disoproxil phosphate, quantity: 291 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; stearic acid; titanium dioxide; lactose monohydrate; hypromellose; triacetin; indigo carmine aluminium lake - tenofovir gh in combination with other antiretroviral agents is indicated for the treatment of hiv infected adults and paediatric patients 12 years of age and older. tenofovir gh is indicated for the treatment of chronic hepatitis b in adults (see clinical trials). tenofovir gh is indicated for the treatment of chronic hepatitis b in paediatric patients 12 years of age and older with compensated liver disease and with evidence of immune active disease, i.e. active viral replication, persistently elevated serum alt levels or evidence of active inflammation.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ruxolitinib phosphate, quantity: 13.2 mg (equivalent: ruxolitinib, qty 10 mg) - tablet - excipient ingredients: hyprolose; povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate type a - jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in patients with primary myelofibrosis, post-polycythemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis.,jakavi is indicated for the treatment of adult patients with polycythemia vera who are resistant to or intolerant of hydroxyurea.,jakavi is indicated for the treatment of patients aged 12 years and older with acute graft-versus-host disease who have inadequate response to corticosteroids.,jakavi is indicated for the treatment of patients aged 12 years and older with chronic graft-versus-host disease who have inadequate response to corticosteroids.